Angiogenesis in cancer and other diseases (original) (raw)

• Goldman, E. The growth of malignant disease in man and the lower animals with special reference to the vascular system. Lancet 2, 1236–1240 (1907).
  Article Google Scholar
• Ide, A. G., Baker, N. H. & Warren, S. L. Vascularization of the Brown-Pearce rabbit epithelioma transplant as seen in the transparent ear chamber. Am. J. Radiol. 42, 891–899 ( 1939).
  Google Scholar
• Algire, G. H. & Chalkley, H. W. Vascular reactions of normal and malignant tissues in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants. J. Natl Cancer Inst. USA 6, 73–85 (1945 ).
  Article Google Scholar
• Greenblatt, M. & Shubik, P. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparant chamber technique. J. Natl Cancer Inst. 41, 111–124 (1968).
  CAS PubMed Google Scholar
• Ehrmann, R. L. & Knoth, M. Choriocarcinoma: transfilter stimulation of vasoproliferation in the hamster cheek pouch studied by light and electron microscopy. J. Natl Cancer Inst. 41, 1329 –1341 (1968).
  CAS PubMed Google Scholar
• Folkman, J. in Cancer Medicine (eds Holland, J. F. et al.) 132– 152 (Decker, Ontario, Canada, 2000).
  Google Scholar
• Gullino, P. M. Angiogenesis and oncogenesis. J. Natl Cancer Inst. 61, 639–643 (1978).
  CAS PubMed Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 ( 2000).
  Article CAS PubMed Google Scholar
• Bouck, N., Stellmach, V. & Hsu, S. C. How tumors become angiogenic. Adv. Cancer Res. 69, 135–174 ( 1996).
  Article CAS PubMed Google Scholar
• Kerbel, R. S. Tumor angiogenesis: past, present and the near future. Carcinogenesis 21, 505–515 ( 2000).
  Article CAS PubMed Google Scholar
• Carmeliet, P. Controlling the cellular brakes. Nature 401, 657–658 (1999).
  Article ADS CAS PubMed Google Scholar
• Fukumura, D. et al. Tumor induction of VEGF promoter activity in stromal cells . Cell 94, 715–725 (1998).
  Article CAS PubMed Google Scholar
• Ramanujan, S., Koenig, G. C., Padera, T. P., Stoll, B. R. & Jain, R. K. Local imbalance of proangiogenic and antiangiogenic factors: a potential mechanism of focal necrosis and dormancy in tumors. Cancer Res. 60, 1442– 1448 (2000).
  CAS PubMed Google Scholar
• Patan, S., Munn, L. L. & Jain, R. K. Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. Microvasc. Res. 51, 260–272 (1996).
  Article CAS PubMed Google Scholar
• Asahara, T., Kalka, C. & Isner, J. M. Stem cell therapy and gene transfer for regeneration . Gene Ther. 7, 451–457 (2000).
  Article CAS PubMed Google Scholar
• Rafii, S. Circulating endothelial precursors: mystery, reality, and promise. J. Clin. Invest. 105, 17–19 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. Nature Med. 6, 389–395 (2000).
  Article CAS PubMed Google Scholar
• Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single vascular endothelial growth factor allele. Nature 380, 435–439 ( 1996).
  Article ADS CAS PubMed Google Scholar
• Ferrara, N. & Alitalo, K. Clinical applications of angiogenic growth factors and their inhibitors. Nature Med. 5, 1359–1364 (1999).
  Article CAS PubMed Google Scholar
• Benjamin, L. E., Golijanin, D., Itin, A., Pode, D. & Keshet, E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, 159–165 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Jain, R. K. Determinants of tumor blood flow: a review. Cancer Res. 48, 2641–2658 (1988).
  CAS PubMed Google Scholar
• Chang, Y. S. et al. Abundance of neoplastic cells in vessel walls of human tumor xenografts. Proc. Am. Assoc. Cancer Res. (in the press).
• Baish, J. W. & Jain, R. K. Fractals and cancer. Cancer Res. 60, 3683–3688 (2000).
  CAS PubMed Google Scholar
• Helmlinger, G., Yuan, F., Dellian, M. & Jain, R. K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nature Med. 3, 177 –182 (1997).
  Article CAS PubMed Google Scholar
• Giaccia, A. J. Hypoxic stress proteins: survival of the fittest. Semin. Radiat. Oncol. 6, 46–58 ( 1996).
  Article CAS PubMed Google Scholar
• Eberhard, A. et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res. 60, 1388–1393 (2000).
  CAS PubMed Google Scholar
• Hobbs, S. K. et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl Acad. Sci. USA 95, 4607–4612 (1998).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Hashizume, H. et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156, 1363 –1380 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F. & Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeabiltiy in angiogenesis . Curr. Top. Microbiol. Immunol. 237, 97 –132 (1999).
  CAS PubMed Google Scholar
• Jain, R. K. et al. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc. Natl Acad. Sci. USA 95, 10820–10825 (1998).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Fukumura, D., Yuan, F., Monsky, W. L., Chen, Y. & Jain, R. K. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am. J. Pathol. 151, 679–688 (1997).
  CAS PubMed PubMed Central Google Scholar
• Fidler, I. J. Modulation of the organ microenvironment for treatment of cancer metastasis . J. Natl Cancer Inst. 87, 1588– 1592 (1995).
  Article CAS PubMed Google Scholar
• Jain, R. K. & Munn, L. L. Leaky vessels? Call Ang1!. Nature Med. 6, 131–132 ( 2000).
  Article CAS PubMed Google Scholar
• Jain, R. K. et al. Leukocyte-endothelial adhesion and angiogenesis in tumors . Cancer Metastasis Rev. 15, 195– 204 (1996).
  Article CAS PubMed Google Scholar
• Eliceiri, B. P. & Cheresh, D. A. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest. 103 , 1227–1230 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, X. et al. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 275, 547–550 (1997).
  Article CAS PubMed Google Scholar
• Arap, W., Pasqualini, R. & Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279, 377–380 (1998).
  Article ADS CAS PubMed Google Scholar
• Leu, A. J., Berk, D. A., Lymboussaki, A., Alitalo, K. & Jain, R. K. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res. 60, 4324–4327 (2000).
  CAS PubMed Google Scholar
• Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J. & Jain, R. K. Solid stress inhibits the growth of multicellular tumor spheroids. Nature Biotechnol. 15, 778–783 (1997).
  Article CAS Google Scholar
• Jeltsch, M. et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice . Science 276, 1423–1425 (1997).
  Article CAS PubMed Google Scholar
• Jain, R. K. Barriers to drug delivery in solid tumors. Sci. Am. 271, 58–65 (1994).
  Article ADS CAS PubMed Google Scholar
• O'Reilly, M. S. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315–328 (1994).
  Article CAS PubMed Google Scholar
• O'Reilly, M. S. et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277–285 (1997).
  Article CAS PubMed Google Scholar
• Gohongi, T. et al. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1 . Nature Med. 5, 1203–1208 (1999).
  Article CAS PubMed Google Scholar
• Hartford, A. C., Gohongi, T., Fukumura, D. & Jain, R. K. Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction. Cancer Res. 60, 2128–2131 (2000).
  CAS PubMed Google Scholar
• Perez Atayde, A. R. et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am. J. Pathol. 150 , 815–821 (1997).
  CAS PubMed PubMed Central Google Scholar
• Bellamy, W. T., Richter, L., Frutiger, Y. & Grogan, T. M. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res. 59, 728– 733 (1999).
  CAS PubMed Google Scholar
• Vikkula, M., Boon, L., Mulliken, J. B. & Olsen, B. R. Molecular basis of vascular anomalies. Trends Cardiovasc. Med. 8, 281–292 ( 1998).
  Article CAS PubMed Google Scholar
• Albini, A. et al. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nature Med. 2, 1371–1375 ( 1996).
  Article CAS PubMed Google Scholar
• Flore, O. et al. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394, 588–592 (1998).
  Article ADS CAS PubMed Google Scholar
• Boulton, A. J. & Malik, R. A. Diabetic neuropathy . Med. Clin. North Am. 82, 909– 929 (1998).
  Article CAS PubMed Google Scholar
• Semenza, G. L. Hypoxia-inducible factor 1: master regulator of O2 homeostasis . Curr. Opin. Genet. Dev. 8, 588– 594 (1998).
  Article CAS PubMed Google Scholar
• Alon, T. et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity . Nature Med. 1, 1024–1028 (1995).
  Article CAS PubMed Google Scholar
• Rabinovitch, M. Pulmonary hypertension: pathophysiology as a basis for clinical decision making . J. Heart Lung Transpl. 18, 1041– 1053 (1999).
  Article CAS Google Scholar
• Pinedo, H. M., Verheul, H. M., D'Amato, R. J. & Folkman, J. Involvement of platelets in tumour angiogenesis? Lancet 352, 1775–1777 (1998).
  Article CAS PubMed Google Scholar
• Seljelid, R., Jozefowski, S. & Sveinbjornsson, B. Tumor stroma. Anticancer Res. 19, 4809–4822 (1999).
  CAS PubMed Google Scholar
• Schaper, W. & Ito, W. D. Molecular mechanisms of coronary collateral vessel growth. Circ. Res. 79, 911–919 (1996).
  Article CAS PubMed Google Scholar
• Coussens, L. M. et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13, 1382–1397 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Heymans, S. et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nature Med. 5, 1135– 1142 (1999).
  Article CAS PubMed Google Scholar
• Carmeliet, P. & Collen, D. Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system . Thromb. Res. 91, 255– 285 (1998).
  Article CAS PubMed Google Scholar
• Buschmann, I. & Schaper, W. The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190, 338–342 (2000).
  Article CAS PubMed Google Scholar
• Silverman, K. J. et al. Angiogenic activity of adipose tissue. Biochem. Biophys. Res. Commun. 153, 347–352 (1988).
  Article CAS PubMed Google Scholar
• Sierra-Honigmann, M. R. et al. Biological action of leptin as an angiogenic factor. Science 281, 1683–1686 ( 1998).
  Article ADS CAS PubMed Google Scholar
• Isner, J. M. & Asahara, T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 103, 1231–1236 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Carmeliet, P. et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nature Med. 5, 495– 502 (1999).
  Article CAS PubMed Google Scholar
• Li, J. et al. PR39, a peptide regulator of angiogenesis. Nature Med. 6, 49–55 (2000 ).
  Article CAS PubMed Google Scholar
• Carmeliet, P. et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485 –490 (1998).
  Article ADS CAS PubMed Google Scholar
• Fidler, I. J. & Ellis, L. M. Chemotherapeutic drugs—more really is not better. Nature Med. 6, 500 –502 (2000).
  Article CAS PubMed Google Scholar
• Rohan, R. M., Fernandez, A., Udagawa, T., Yuan, J. & D'Amato, R. J. Genetic heterogeneity of angiogenesis in mice. FASEB J. 14, 871– 876 (2000).
  Article CAS PubMed Google Scholar
• Carmeliet, P. et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98, 147–157 ( 1999).
  Article CAS PubMed Google Scholar
• Bajou, K. et al. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nature Med. 4, 923–928 (1998).
  Article CAS PubMed Google Scholar
• Carmeliet, P. & Collen, D. Transgenic mouse models in angiogenesis and cardiovascular disease. J. Pathol. 190, 387–405 (2000).
  Article CAS PubMed Google Scholar
• Jain, R. K., Schlenger, K., Höckel, M. & Yuan, F. Quantitative angiogenesis assays: progress and problems. Nature Med. 3, 1203–1208 ( 1997).
  Article CAS PubMed Google Scholar
• Tsuzuki, Y. et al. VEGF modulation by targeting HIF-1alpha/HRE/VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. (in the press).
• Leunig, M. et al. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res. 52, 6553 –6560 (1992).
  CAS PubMed Google Scholar